No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
Agudo, A.; Sala, N.; Pera, G.; Capella, G.; Berenguer, A.; Garcia, N.; Palli, D.; Boeing, H.H.; Del Giudice, G.; Saieva, C.; Carneiro, F.; Berrino, F.; Sacerdote, C.; Tumino, R.; Panico, S.; Berglund, G.; Siman, H.; Stenling, R.; Hallmans, G.; Martinez, C.; Amiano, P.; Barricarte, A.; Navarro, C.; Quiros, J.R.; Allen, N.; Key, T.J.; Bingham, S; Khaw, K.T.; Linseisen, J.; Nagel, G.; Overvad, K.; Tjonneland, A.; Olsen, A.; Bueno de Mesquita, H.B.; Boshuizen, H.C.; Peeters, P.H.M.; Numans, M.E.; Clavel-Chapelon, F.; Boutron-Ruault, M.C.; Trichopoulou, A.; Lund, E.; Blaker, H.; Jenab, M.; Ferrari, P.; Norat, T.; Riboli, E.; Gonzalez, C.A.
(2006) Cancer Epidemiology Biomarkers & Prevention, volume 15, issue 5, pp. 1043 - 1045
(Article)
Download/Full Text
ISSN: 1055-9965
Publisher: American Association for Cancer Research Inc.
(Peer reviewed)